Skip to content

YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) in Elementary Schools

Integration of the YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) Into Elementary Schools in Germany

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03796754
Enrollment
250
Registered
2019-01-08
Start date
2019-01-21
Completion date
2020-02-15
Last updated
2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Psychological

Brief summary

The aim of this study is a first evaluation of the effectiveness of the YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) to evaluate potential effects in stress reduction and concomitant psychological parameters.

Interventions

BEHAVIORALYoBEKA

The teachers and students of the YoBEKA study arm receive a guided YoBEKA practice from an experienced YoBEKA trainer during the regular 4 month intervention period. The YoBEKA program is based on a combination of different, easy to perform exercises appropriate to the school situation, consisting of postures, verses for speech, song and movement, affirmations in movement to promote balance and coordination, and various rest and silence exercises to promote body awareness and relaxation techniques. The teaching is ideologically neutral and without religious background. The participating teachers receive an initial two-hour YoBEKA introductory course. Every 2 weeks there is a one to two-hour training course. The pedagogical specialists are supported once a week by an experienced YoBEKA trainer. The teachers are encouraged to integrate the learned exercises independently and regularly into their everyday school life.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Students from participating primary schools in Berlin aged 6-12 years * Written declaration of consent of the parent or legal guardian

Exclusion criteria

* Serious chronic or acute diseases * Immobility or serious restriction for gymnastic exercises due to orthopaedic, neurological or other medical causes * Participation in another study

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire on the assessment of stress and stress management in childhood and adolescence - Revision (SSKJ 3-8 R)Change baseline, 4 monthsFilled out by students, assessing composite score (range 29-94): subscale 1 (stress-vulnerability \[range 7-28\]) summed with subscale 3 (stress symptoms and well-being \[range 22-66\]), lower score meaning a better outcome

Secondary

MeasureTime frameDescription
Inventory of the quality of life of children and adolescents (KIDSCREEN-27 children)Change Baseline, 4 months, 12 monthsFilled out by students, assessing full scale, range 27-135, lower score meaning a better outcome
Perceived Stress Scale (PSS)Change Baseline, 4 months, 12 monthsFilled out by teachers, assessing full scale, range 0-40, lower score meaning a better outcome
Teacher anxiety and stress inventory (LASI)Change Baseline, 4 months, 12 monthsFilled out by teachers, assessing LASI 2, range 46-230, higher score meaning a better outcome
Screening for somatoform disorders of childhood and adolescence (SOMS-E)Change Baseline, 4 months, 12 monthsFilled out by parents, assessing full scale, range 55-110, lower score meaning a better outcome
Inventory of the quality of life of children and adolescents (KIDSCREEN-52 parents)Change Baseline, 4 months, 12 monthsFilled out by parents, assessing full scale, range 27-135, lower score meaning a better outcome

Other

MeasureTime frameDescription
Heart rate variabilityBaseline, 4 months, 12 monthsAssessed with Faros 180 over 24 hours
Qualitative interviews4 months, 12 monthsSemi-structured interviews in focus groups

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026